New drug interaction study aims to make future treatments safer

NCT ID NCT06949124

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This completed phase 1 study tested how SHR7280, a drug being developed for endometriosis and uterine fibroids, affects the way the body processes six other common drugs. Twenty healthy men took SHR7280 along with midazolam, warfarin, omeprazole, digoxin, and rosuvastatin to see if interactions occur. The results will help guide safe dosing when SHR7280 is used alongside other medications.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
SHR7280 tablets
What this could lead to
If successful, this study will help doctors understand how SHR7280 interacts with common medications, making future treatments safer for people with endometriosis, uterine fibroids, or undergoing assisted reproduction.
What could go wrong
This is an early-stage drug interaction study in just 20 healthy men, not patients. It does not test whether SHR7280 works for any disease, and results may not predict effects in women or people with medical conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASSISTED REPRODUCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Zhongnan hospital of Wuhan University

    Wuhan, Hubei, 430071, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.